Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:12 UTC |
---|
HMDB ID | HMDB0000821 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Phenylacetylglycine |
---|
Description | Phenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:. acyl-CoA + glycine < -- > CoA + N-acylglycine. Phenylacetylglycine or PAG is a glycine conjugate of phenylacetic acid. Phenylacetic acid may arise from exposure to styrene (plastic) or through the consumption of fruits and vegetables. Phenylacetic acid is used in some perfumes, possessing a honey-like odour in low concentrations, and is also used in penicillin G production. PAG is a putative biomarker of phospholipidosis. Urinary PAG is elevated in animals exhibiting abnormal phospholipid accumulation in many tissues and may thus be useful as a surrogate biomarker for phospholipidosis. (PMID: 15764292 ) The presence of phenylacetylglycine in urine has been confirmed for dogs, rats and mice. However, the presence of this compound in human urine is controversial. GC-MS studies have not found this compound (PMID: 7492634 ) while NMR studies claimed to have identified it (PMID: 21167146 ). It appears that phenylacetylglycine may sometimes be mistaken for phenylacetylglutamine via NMR. |
---|
Structure | OC(=O)CNC(=O)CC1=CC=CC=C1 InChI=1S/C10H11NO3/c12-9(11-7-10(13)14)6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,12)(H,13,14) |
---|
Synonyms | Value | Source |
---|
N-Phenacetylglycine | ChEBI | N-Phenylacetylglycine | ChEBI | Phenaceturic acid | ChEBI | Phenacetylglycine | ChEBI | Phenacetate | Generator | Phenacetic acid | Generator | ((Phenylacetyl)amino)acetic acid | HMDB | N-(Phenylacetyl)-glycine | HMDB | N-(Phenylacetyl)glycine | HMDB | PAA | HMDB | PAG | HMDB | Phenaceturate | HMDB | Phenylacetyl glycine | HMDB | [(Phenylacetyl)amino]acetate | HMDB | [(Phenylacetyl)amino]acetic acid | HMDB | Phenylacetylglycine | MeSH |
|
---|
Chemical Formula | C10H11NO3 |
---|
Average Molecular Weight | 193.1992 |
---|
Monoisotopic Molecular Weight | 193.073893223 |
---|
IUPAC Name | 2-(2-phenylacetamido)acetic acid |
---|
Traditional Name | phenylacetylglycine |
---|
CAS Registry Number | 500-98-1 |
---|
SMILES | OC(=O)CNC(=O)CC1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C10H11NO3/c12-9(11-7-10(13)14)6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,12)(H,13,14) |
---|
InChI Key | UTYVDVLMYQPLQB-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | N-acyl-alpha amino acids |
---|
Alternative Parents | |
---|
Substituents | - N-acyl-alpha-amino acid
- Monocyclic benzene moiety
- Benzenoid
- Carboximidic acid
- Carboximidic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 7.3 mg/mL at 11 °C | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Phenylacetylglycine,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CNC(=O)CC1=CC=CC=C1 | 1906.9 | Semi standard non polar | 33892256 | Phenylacetylglycine,1TMS,isomer #2 | C[Si](C)(C)N(CC(=O)O)C(=O)CC1=CC=CC=C1 | 1873.5 | Semi standard non polar | 33892256 | Phenylacetylglycine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 1854.8 | Semi standard non polar | 33892256 | Phenylacetylglycine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 1904.6 | Standard non polar | 33892256 | Phenylacetylglycine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2227.5 | Standard polar | 33892256 | Phenylacetylglycine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CNC(=O)CC1=CC=CC=C1 | 2155.5 | Semi standard non polar | 33892256 | Phenylacetylglycine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CC(=O)O)C(=O)CC1=CC=CC=C1 | 2093.8 | Semi standard non polar | 33892256 | Phenylacetylglycine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2344.2 | Semi standard non polar | 33892256 | Phenylacetylglycine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2327.5 | Standard non polar | 33892256 | Phenylacetylglycine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2464.5 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Phenylacetylglycine EI-B (Non-derivatized) | splash10-0006-9000000000-96f6d1819364e0910beb | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylacetylglycine GC-EI-TOF (Non-derivatized) | splash10-0udl-5930000000-6e0622de46a05b80d685 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylacetylglycine GC-EI-TOF (Non-derivatized) | splash10-0006-9610000000-b8948d031afc0e4b8f78 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylacetylglycine EI-B (Non-derivatized) | splash10-0006-9000000000-96f6d1819364e0910beb | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylacetylglycine GC-EI-TOF (Non-derivatized) | splash10-0udl-5930000000-6e0622de46a05b80d685 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylacetylglycine GC-EI-TOF (Non-derivatized) | splash10-0006-9610000000-b8948d031afc0e4b8f78 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglycine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9500000000-50b56f103c1a79f65878 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglycine GC-MS (1 TMS) - 70eV, Positive | splash10-006x-9200000000-5d39e42ac2b4d7b6f726 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglycine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglycine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglycine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglycine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-004l-9100000000-134ddfbf19f2ee4e9260 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0006-9000000000-9656d3b4670efd4db2e3 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0006-9000000000-9cf5ff47848cf5bf99b2 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine EI-B (VARIAN MAT-44) , Positive-QTOF | splash10-0006-9000000000-f37d59edacbcf679b420 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 20V, Positive-QTOF | splash10-0006-9200000000-92c7f1e2376eb0e84b36 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 10V, Positive-QTOF | splash10-002f-9200000000-c48677787f705755d93f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 30V, Positive-QTOF | splash10-0006-9300000000-dd5f78904d0d0dacb641 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 40V, Positive-QTOF | splash10-0006-9300000000-1acb6b8d75e7381ccbde | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 30V, Positive-QTOF | splash10-0596-9100000000-415a6a1ccc4a5a25ad4f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 10V, Positive-QTOF | splash10-002f-9100000000-52063d451d15512ae652 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 35V, Positive-QTOF | splash10-0006-9000000000-b4cfc8b9dad7406c720f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 0V, Positive-QTOF | splash10-002f-9000000000-88eadbe8bb1b30f341b0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 40V, Negative-QTOF | splash10-00di-9000000000-abf76489fbf1b18e56aa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 30V, Negative-QTOF | splash10-00di-9000000000-1168dca79ce76e8ff744 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 10V, Negative-QTOF | splash10-00di-9000000000-709de7804cd48ddac3b5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 35V, Negative-QTOF | splash10-00di-9000000000-668624127e5eb3cd947a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglycine 20V, Negative-QTOF | splash10-00di-9000000000-f0284ab582fc7a2b28c4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 10V, Positive-QTOF | splash10-00dl-9600000000-96499e21a08e5d190040 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 20V, Positive-QTOF | splash10-00fr-9200000000-aeac60944271030f9751 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 40V, Positive-QTOF | splash10-00bc-9000000000-4caba04f2e229a8013b4 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 10V, Negative-QTOF | splash10-0006-0900000000-899f25422883181dbe57 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 20V, Negative-QTOF | splash10-006x-4900000000-433c13250fe2463708f4 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 40V, Negative-QTOF | splash10-006x-9200000000-0b6ae74cd7a7ddce62d7 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 10V, Negative-QTOF | splash10-00di-9000000000-e21745e55a3af36629b3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglycine 20V, Negative-QTOF | splash10-00di-9000000000-078d0d5a533b72168681 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 19.55 +/- 7.98 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0366–0.1361 umol/mmol creatinine | Adult (25-30 years old) | Both | Not Available | | details | Urine | Detected and Quantified | 0.0394–0.1695 umol/mmol creatinine | Adult (25-30 years old) | Both | Not Available | | details | Urine | Detected and Quantified | 0.0370–0.1314 umol/mmol creatinine | Adult (25-30 years old) | Both | Not Available | | details | Urine | Detected and Quantified | 65 +/- 15 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (24-38years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 74.841 +/- 30.788 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Urine | Detected and Quantified | 100 +/- 60 umol/mmol creatinine | Adult (>18 years old) | Both | Heart failure | | details | Urine | Detected and Quantified | 61.775 +/- 51.294 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Heart failure |
---|
- Kang SM, Park JC, Shin MJ, Lee H, Oh J, Ryu DH, Hwang GS, Chung JH: (1)H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clin Biochem. 2011 Mar;44(4):293-9. doi: 10.1016/j.clinbiochem.2010.11.010. Epub 2010 Dec 15. [PubMed:21167146 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | - 610247 (Eosinophilic esophagitis)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022266 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 61452 |
---|
KEGG Compound ID | C05598 |
---|
BioCyc ID | CPD-11715 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | 4237 |
---|
PubChem Compound | 68144 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 27480 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | M02723 |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Ford, Jared H. Convenient synthesis of phenaceturic acid. Journal of the American Chemical Society (1949), 71 3842. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Wang Y, Holmes E, Nicholson JK, Cloarec O, Chollet J, Tanner M, Singer BH, Utzinger J: Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12676-81. Epub 2004 Aug 16. [PubMed:15314235 ]
- Ito T, Kidouchi K, Sugiyama N, Kajita M, Chiba T, Niwa T, Wada Y: Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric analysis of glycine conjugates and urinary isovalerylglycine in isovaleric acidemia. J Chromatogr B Biomed Appl. 1995 Aug 18;670(2):317-22. [PubMed:8548022 ]
- Matsumoto M, Zhang CH, Kosugi C, Matsumoto I: Gas chromatography-mass spectrometric studies of canine urinary metabolism. J Vet Med Sci. 1995 Apr;57(2):205-11. [PubMed:7492634 ]
- Kang SM, Park JC, Shin MJ, Lee H, Oh J, Ryu DH, Hwang GS, Chung JH: (1)H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clin Biochem. 2011 Mar;44(4):293-9. doi: 10.1016/j.clinbiochem.2010.11.010. Epub 2010 Dec 15. [PubMed:21167146 ]
- Delaney J, Neville WA, Swain A, Miles A, Leonard MS, Waterfield CJ: Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model. Biomarkers. 2004 May-Jun;9(3):271-90. [PubMed:15764292 ]
|
---|